Here is the latest stock price and chart of Torrent Pharma. For more details, see the Torrent Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
EXPIRES TOMORROW: Full Transcript of Our Urgent Broadcast on India's Revival
Live BSE Quotes | Apr 16, 2021 (Close) | ||
---|---|---|---|
Price (Rs)2,619.15 | Open (Rs) 2,570.90 | High (Rs) 2,630.00 | Low (Rs) 2,552.00 |
% Change2.06 | Volume 11,720 | Value (Rs) 30,392,850 | 52-Week H/L 3,040.00 / 2,227.20 |
Live NSE Quotes | Apr 16, 2021 (Close) | ||
---|---|---|---|
Price (Rs)2,619.50 | Open (Rs) 2,570.00 | High (Rs) 2,631.00 | Low (Rs) 2,552.10 |
% Change2.12 | Volume 274,608 | Value (Rs) 712,248,693 | 52-Week H/L 3,031.20 / 2,225.00 |
Change | |||||
---|---|---|---|---|---|
1 Day 2.06% | 1 Month 5.99% | 3 Months -0.66% | 1 Year 12.47% | 5 Years (CAGR)* 12.22% | 10 Years (CAGR)* 24.38% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 70.66 | P/E Ratio (x) 37.07 | Market Cap (Rs m) 443,317.33 | P/BV (x) 9.38 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
TORRENT PHARMA last traded price was up 2.1% to Rs 2,619.2 on the BSE. On the NSE, TORRENT PHARMA last traded price was up 2.1% to Rs 2,619.5. The total volume of shares traded was 0.3 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 1.9%. And the benchmark S&P BSE SENSEX was at 48,832.0 (up 0.1%).
Over the last 30 days, the TORRENT PHARMA share price is up 7.7%. And over the last one year, TORRENT PHARMA share price is up 13.9%.
What else is happening in the markets today? Dig in...
Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.
For the quarter ended September 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 27.0% YoY). Sales on the other hand came in at Rs 20 bn (up 0.6% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.
For the quarter ended June 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 48.6% YoY). Sales on the other hand came in at Rs 21 bn (up 1.7% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
Narayana Murthy was one of the first unicorn founders to get the backing of this entity...
In this video, I'll you what I think is the real reason behind yesterday's market crash.
This ignored sector could deliver big short-term profits.
More